KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Common Equity: 2019-2024

Historic Common Equity for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $476.7 million.

  • Hims & Hers Health's Common Equity rose 32.03% to $581.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $581.0 million, marking a year-over-year increase of 32.03%. This contributed to the annual value of $476.7 million for FY2024, which is 38.57% up from last year.
  • Latest data reveals that Hims & Hers Health reported Common Equity of $476.7 million as of FY2024, which was up 38.57% from $344.0 million recorded in FY2023.
  • Hims & Hers Health's 5-year Common Equity high stood at $476.7 million for FY2024, and its period low was -$146.9 million during FY2020.
  • For the 3-year period, Hims & Hers Health's Common Equity averaged around $377.5 million, with its median value being $344.0 million (2023).
  • In the last 5 years, Hims & Hers Health's Common Equity slumped by 3,037.47% in 2020 and then surged by 327.83% in 2021.
  • Over the past 5 years, Hims & Hers Health's Common Equity (Yearly) stood at -$146.9 million in 2020, then skyrocketed by 327.83% to $334.6 million in 2021, then fell by 6.84% to $311.7 million in 2022, then increased by 10.36% to $344.0 million in 2023, then spiked by 38.57% to $476.7 million in 2024.